Co-Founder / Head of Finance & Transaction Strategy

Job Description

Job Description

Co-Founder / Head of Finance & Transaction Strategy

Biotechnology NewCo – drug repurposing / 505(b)(2) CNS Development Program
Location: Remote (United States)
Position Type: Executive-Level | Equity & Performance-Based Compensation
Company: Confidential NewCo (sponsored by Slingshot Advisory)

Position Summary

The company is forming a new biotechnology development entity focused on advancing a repurposed central nervous system (CNS) drug with a highly favorable 505(b)(2) regulatory path in the United States.

We are seeking an experienced Head of Finance & Transaction Strategy to serve as a senior executive and co-founder for the development and execution of the company’s initial corporate structure, capitalization strategy, and transaction pathway.

The initial strategic plan includes:

• formation of the legal and financial structure of the NewCo,
• development of the capitalization strategy for a Phase 0–2 clinical development plan,
• identification and evaluation of potential acquisition vehicles (e.g., clean shell, microcap public company, or specialty pharma platform),
• and execution of a transaction pathway such as a reverse-merger, asset acquisition, or alternative public-ready structure.

This role is central to establishing the corporate and financial backbone of the NewCo.

Key Responsibilities

Corporate Structure & Governance

• Oversee corporate formation from LLC to Delaware C-Corp, including corporate governance, cap table design, and compliance documentation,
• Drive the development of the Phase 0-2 capitalization strategy,
• Lead the evaluation of corporate chassis candidates, including OTCQB/OTCQX shells, microcap biotechs, or specialty pharma platforms,
• Manage the development of financial controls, accounting architecture, and early-stage operations.

Finance & Capital Strategy

• Build financial models for Phase 0–Phase 2 development pathways, including regulatory, CMC, and clinical budgets,
• Develop multi-stage capitalization strategies incorporating SPVs, PIPEs, private placements, and structured equity instruments,
• Prepare financial materials for investors, advisors, regulatory partners, and potential merger counterparties,
• Lead financial diligence and risk assessment for acquisition targets.

Legal & Transaction Execution

• Work with external counsel on SEC, OTC, or uplist readiness requirements,
• Support evaluation of transaction structures including reverse mergers, RTOs, or asset acquisitions,
• Manage financial, corporate, and legal diligence processes for target companies or shells,
• Participate in negotiation and drafting of transaction terms, closing documents, and compliance filings.

External Relations & Advisory Coordination

• Engage with capital markets participants including microcap investors, family offices, and biotech-specialized funds,
• Coordinate with investment bankers, transaction attorneys, and advisors,
• Represent the company professionally in strategic and financial discussions.

Required Qualifications

• 10+ years in finance, corporate development, investment banking, private equity, or corporate law, ideally with experience in biotechnology, specialty pharma, or regulated industries,
• Demonstrated experience with reverse mergers, SPAC transactions, microcap deals, PIPEs, or complex corporate transactions,
• Strong understanding of financial modeling, capitalization structures, and corporate governance,
• Experience evaluating acquisition targets, managing due diligence, and closing transactions,
• Ability to operate in a dynamic early-stage environment with minimal structure,
• Excellent analytical, organizational, and communication skills.

Preferred Qualifications

• Experience with 505(b)(2) assets, CNS therapeutics, specialty pharmaceuticals, or drug delivery platforms,
• Direct experience with public-company reporting or SEC compliance,
• Background working with small public companies, clean shells, or microcap biotech,
• Prior operational finance or CFO experience in R&D-intensive environments.

Compensation Structure

• Founder-level equity position in the NewCo,
• Performance-based incentives linked to transaction milestones and capital events,
• Flexible cash compensation structure based on candidate experience and involvement,
• Opportunity to transition into full-time CFO or COO role post-transaction.

This position is not structured as a short-term consulting engagement; it is an executive leadership role for a candidate interested in contributing meaningfully to company formation and long-term value creation.

Application Instructions

Please submit the following to brian@ssh.ceo:

1. Resume or CV
2. Brief cover letter describing relevant experience
3. Summary of prior transaction experience (if applicable)